Ireland· IE-PA-EU/1/23/1740/001-002
Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)
A respiratorisches-synzytial-virus impfstoffe product containing recombinant respiratory syncytial virus pre-fusion f protein, adjuvanted with as01e, registered in Ireland by GlaxoSmithKline Biologicals. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Respiratorisches-synzytial-virus impfstoffe is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BX05 (respiratorisches-synzytial-virus impfstoffe), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Respiratorisches-synzytial-virus impfstoffe · ATC J07BX05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E
- Manufacturer
- GlaxoSmithKline Biologicals
- Country
- Ireland (IE)
- ATC code
- J07BX05
- ATC class
- Respiratorisches-Synzytial-Virus Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/23/1740/001-002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX05
Respiratorisches-synzytial-virus impfstoffe, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5767049e-a3e4-4812-82c8-e9e25260ebf0 GET /v1/drugs/5767049e-a3e4-4812-82c8-e9e25260ebf0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and suspension for suspension for injection",
"routes": [
"Intramuscular use"
],
"source": "hpra",
"atc_all": [
"J07BX05"
],
"strength": null,
"pa_number": "EU/1/23/1740/001-002",
"substances": [
"Recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "06/06/2023",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about respiratorisches-synzytial-virus impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.